News Chart PixarBio Corporation

Equities

Delayed OTC Markets Other stock markets 03:17:43 2023-06-27 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2018	PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain	CI
2018	Pixarbio Corporation Announces the Removal of Katrin Holzhaus as Chief Administration Officer and Corporate Secretary of the Company	CI

3f.QRSyaZDs2kFXP03Pq0xQX5O8HOb8sGQDeK0lYOr7p2E.AF3-G9qutTM2DAj2hho5BvL6frOdhjRMIOBKNN2e4S8vYfUi-rrtERF1eQ~f22984b6e462ff7cbf29c2c9642af2eb